BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23848514)

  • 1. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
    Wada T; Ishimoto T; Seishima R; Tsuchihashi K; Yoshikawa M; Oshima H; Oshima M; Masuko T; Wright NA; Furuhashi S; Hirashima K; Baba H; Kitagawa Y; Saya H; Nagano O
    Cancer Sci; 2013 Oct; 104(10):1323-9. PubMed ID: 23848514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
    Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
    Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.
    Halldórsdóttir AM; Sigurdardóttrir M; Jónasson JG; Oddsdóttir M; Magnússon J; Lee JR; Goldenring JR
    Dig Dis Sci; 2003 Mar; 48(3):431-41. PubMed ID: 12757153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
    Jeong H; Lee B; Kim KH; Cho SY; Cho Y; Park J; Lee Y; Oh Y; Hwang BR; Jang AR; Park JH; Park JH; Jeong SH; Lee D; Lee YC; Lim KM; Goldenring JR; Nam KT
    Gastroenterology; 2021 Sep; 161(3):953-967.e15. PubMed ID: 34116028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
    Radyk MD; Burclaff J; Willet SG; Mills JC
    Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension.
    Isobe S; Kataoka M; Endo J; Moriyama H; Okazaki S; Tsuchihashi K; Katsumata Y; Yamamoto T; Shirakawa K; Yoshida N; Shimoda M; Chiba T; Masuko T; Hakamata Y; Kobayashi E; Saya H; Fukuda K; Sano M
    Am J Respir Cell Mol Biol; 2019 Sep; 61(3):367-379. PubMed ID: 30897333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
    Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
    Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
    Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
    Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
    Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
    Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of SPEM and its standing in the preneoplastic process.
    Weis VG; Goldenring JR
    Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.
    Ishimoto T; Nagano O; Yae T; Tamada M; Motohara T; Oshima H; Oshima M; Ikeda T; Asaba R; Yagi H; Masuko T; Shimizu T; Ishikawa T; Kai K; Takahashi E; Imamura Y; Baba Y; Ohmura M; Suematsu M; Baba H; Saya H
    Cancer Cell; 2011 Mar; 19(3):387-400. PubMed ID: 21397861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
    Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
    Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaplasia in the Stomach-Precursor of Gastric Cancer?
    Kinoshita H; Hayakawa Y; Koike K
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
    Thanee M; Loilome W; Techasen A; Sugihara E; Okazaki S; Abe S; Ueda S; Masuko T; Namwat N; Khuntikeo N; Titapun A; Pairojkul C; Saya H; Yongvanit P
    Cancer Sci; 2016 Jul; 107(7):991-1000. PubMed ID: 27176078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review).
    Chong Y; Yu D; Lu Z; Nie F
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38299264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.
    Riera KM; Jang B; Min J; Roland JT; Yang Q; Fesmire WT; Camilleri-Broet S; Ferri L; Kim WH; Choi E; Goldenring JR
    J Pathol; 2020 Jul; 251(3):336-347. PubMed ID: 32432338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
    Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
    Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.